Literature DB >> 11267457

Pretransplant immunosuppression for pancreas transplants alone in nonuremic diabetic recipients.

D E Sutherland1, R G Gruessner, A Humar, R Kandaswamy, J S Najarian, D L Dunn, A Gruessner.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11267457     DOI： 10.1016/s0041-1345(00)02629-4

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade.

Authors:  Andrew M Posselt; Gregory L Szot; Lynda A Frassetto; Umesh Masharani; Mehdi Tavakol; Raj Amin; Joan McElroy; Marissa D Ramos; Robert K Kerlan; Lawrence Fong; Flavio Vincenti; Jeffrey A Bluestone; Peter G Stock
Journal:  Transplantation       Date:  2010-12-27       Impact factor: 4.939

2.  Islet transplantation in type 1 diabetics using an immunosuppressive protocol based on the anti-LFA-1 antibody efalizumab.

Authors:  A M Posselt; M D Bellin; M Tavakol; G L Szot; L A Frassetto; U Masharani; R K Kerlan; L Fong; F G Vincenti; B J Hering; J A Bluestone; P G Stock
Journal:  Am J Transplant       Date:  2010-08       Impact factor: 8.086

3.  A Comparative Analysis of the Safety, Efficacy, and Cost of Islet Versus Pancreas Transplantation in Nonuremic Patients With Type 1 Diabetes.

Authors:  S Moassesfar; U Masharani; L A Frassetto; G L Szot; M Tavakol; P G Stock; A M Posselt
Journal:  Am J Transplant       Date:  2015-11-23       Impact factor: 8.086
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.